An oral imidazotetrazinone methylating agent that has demonstrated schedule-dependent activity in several cancers, including gliomas.


Public Health Social Policy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Springer Science+Business Media LLC 2010

Personalised recommendations